TY - JOUR
T1 - A Phthalocyanine-ortho-Carborane Conjugate for Boron Neutron Capture Therapy
T2 - Synthesis, Physicochemical Properties, and in vitro Tests
AU - Nar, Ilgın
AU - Bortolussi, Silva
AU - Postuma, Ian
AU - Atsay, Armağan
AU - Berksun, Ekin
AU - Viola, Elisa
AU - Ferrari, Cinzia
AU - Cansolino, Laura
AU - Ricciardi, Giampaolo
AU - Donzello, Maria Pia
AU - Hamuryudan, Esin
N1 - Publisher Copyright:
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2019/4
Y1 - 2019/4
N2 - Boronated molecular systems can be applied to boron neutron capture therapy (BNCT). Among these systems, carborane-containing phthalocyanines (Pcs) are the most promising BNCT agents. Herein we report the new zinc (II) complex of the hexacationic Pc 6, which has been obtained as iodide salt through quaternization of the neutral precursor with methyl iodide. Compound 6 was synthesized over a sequence of four steps. The complex, and its precursors as well, were characterized by a combination of spectroscopic techniques, and their structures assessed by 1 H, 13 C, 11 B, and two-dimensional NMR spectroscopy experiments. Together with a marked tendency to aggregate, 6 showed appreciable solubility in water. Singlet oxygen quantum yield (Φ Δ ) of 0.38, and fluorescence quantum yield (Φ F ) of 0.13 were obtained for 6 in a DMF solution. The complex proved to be very effective in enriching UMR-106 cells with 10 B, showing very good performance even in case of very low concentrations exposure, i. e. 1 ppm, that moreover resulted in a mild cytotoxic effect. Such a feature can be related to the polycationic nature of the complex, and hence to the well-known propensity of positively charged species to enter the cellular membrane or to adhere to its external surface.
AB - Boronated molecular systems can be applied to boron neutron capture therapy (BNCT). Among these systems, carborane-containing phthalocyanines (Pcs) are the most promising BNCT agents. Herein we report the new zinc (II) complex of the hexacationic Pc 6, which has been obtained as iodide salt through quaternization of the neutral precursor with methyl iodide. Compound 6 was synthesized over a sequence of four steps. The complex, and its precursors as well, were characterized by a combination of spectroscopic techniques, and their structures assessed by 1 H, 13 C, 11 B, and two-dimensional NMR spectroscopy experiments. Together with a marked tendency to aggregate, 6 showed appreciable solubility in water. Singlet oxygen quantum yield (Φ Δ ) of 0.38, and fluorescence quantum yield (Φ F ) of 0.13 were obtained for 6 in a DMF solution. The complex proved to be very effective in enriching UMR-106 cells with 10 B, showing very good performance even in case of very low concentrations exposure, i. e. 1 ppm, that moreover resulted in a mild cytotoxic effect. Such a feature can be related to the polycationic nature of the complex, and hence to the well-known propensity of positively charged species to enter the cellular membrane or to adhere to its external surface.
KW - boron neutron capture therapy
KW - cancer
KW - carboranes
KW - photodynamic therapy
KW - phthalocyanines
UR - http://www.scopus.com/inward/record.url?scp=85061188051&partnerID=8YFLogxK
U2 - 10.1002/cplu.201800560
DO - 10.1002/cplu.201800560
M3 - Article
C2 - 31939222
AN - SCOPUS:85061188051
SN - 2192-6506
VL - 84
SP - 345
EP - 351
JO - ChemPlusChem
JF - ChemPlusChem
IS - 4
ER -